Viewing Study NCT00313820


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-01-27 @ 6:34 AM
Study NCT ID: NCT00313820
Status: COMPLETED
Last Update Posted: 2021-02-09
First Post: 2006-04-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Central Neuropathic Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Post-stroke pain, pregabalin View